Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Celldex Therapeutics (CLDX) Gross Profit (2024 - 2025)

Celldex Therapeutics has reported Gross Profit over the past 6 years, most recently at -$1.1 million for Q4 2025.

  • Quarterly results put Gross Profit at -$1.1 million for Q4 2025, down 152.16% from a year ago — trailing twelve months through Dec 2025 was -$4.5 million (down 415.9% YoY), and the annual figure for FY2025 was -$4.5 million, down 415.97%.
  • Gross Profit for Q4 2025 was -$1.1 million at Celldex Therapeutics, down from -$1.1 million in the prior quarter.
  • Over the last five years, Gross Profit for CLDX hit a ceiling of $2.1 million in Q3 2024 and a floor of -$1.5 million in Q1 2025.